Advanced Medicine

Will 3D inkjet printing enable the manufacture of personalized tablets?

Nominations are now open for The Medicine Maker 2020 Power List.

As long as payers recognize the value of a curative treatment and manufacturers are flexible with payment plans, patients will have access to ATMPs.

For manufacturers, educating stakeholders, generating evidence and putting the patient first are key to getting value based contracts right.

Are healthcare systems and manufacturers ready to embrace evidence-based pricing to lessen the impact of upfront costs of advanced therapies?

Angela Osborne has created her own space in the industry and is helping the cell and gene therapy industry bloom.

If cell and gene therapy products are to successfully reach patients, then the industry will need more facilities capable of manufacturing them.

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.

Nick Crabb explains the UK’s health technology assessment agency's (NICE's) approach to cell and gene therapies.

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.